Suchergebnisse - (Person:"Wang, Yeming")

PubPharm (13)

1

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply

enthalten in: The New England journal of medicine | 2024

von Wang, Y. | Hu, H. | Cao, B.

CommentOn: N Engl J Med. 2024 Jan 18;390(3):230-241. - PMID 38231624

2

Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

enthalten in: The New England journal of medicine | 2024

von Cao, B. | Wang, Y. | Lu, H. | +28

CommentIn: N Engl J Med. 2024 Apr 25;390(16):1533-1534. - PMID 38657253

3

Impact of Metagenomic Next-Generation Sequencing of Bronchoalveolar Lavage Fluid on Antimicrobial Stewardship in Patients With Lower Respiratory Tract Infections : A Retrospective Cohort Study

enthalten in: The Journal of infectious diseases | 2024

von Yan, M. | Zou, X. | Wang, Y. | +6

4

The combined effect of oseltamivir and favipiravir on influenza A virus evolution in patients hospitalized with severe influenza

enthalten in: Antiviral research | 2023

von Mu, S. | Zou, X. | Wang, Y. | +4

5

Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Liu, Z. | Li, X. | Fan, G. | +15

6

Endpoints for randomized controlled clinical trials for COVID-19 treatments

enthalten in: Clinical trials (London, England) | 2020

von Dodd, L. | Follmann, D. | Wang, J. | +12

CommentIn: Clin Trials. 2021 Apr;18(2):263-264. - PMID 33322940

7

Remdesivir and COVID-19 - Authors' reply

enthalten in: Lancet (London, England) | 2020

von Wang, Y. | Gu, X. | Xu, J. | +2

CommentOn: Lancet. 2020 Oct 3;396(10256):952. - PMID 33010830

8

Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19 : study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

enthalten in: Trials | 2020

von Wang, Y. | Zhou, F. | Zhang, D. | +22

9

Remdesivir in adults with severe COVID-19 : a randomised, double-blind, placebo-controlled, multicentre trial

enthalten in: Lancet (London, England) | 2020

von Wang, Y. | Zhang, D. | Du, G. | +43

CommentIn: Lancet. 2020 May 16;395(10236):1525-1527. - PMID 32423580

10

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

enthalten in: The New England journal of medicine | 2020

von Cao, B. | Wang, Y. | Wen, D. | +62

CommentIn: N Engl J Med. 2020 May 7;382(19):1851-1852. - PMID 32187463